Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICH Quality Discussion Group Canvasses Members, Prepares Additional Guideline Proposals

Executive Summary

The ICH Informal Quality Discussion Group considers an array of proposed new and revised quality guidelines and asks members for additional ideas.

You may also be interested in...



ICH To Add Guidance On Impurities, Viral Safety, Risk Management And Quality Overall Summary

The ICH Management Committee has endorsed four quality topics for revision in its workplan recommended by its Quality Discussion Group, including a groundbreaking new guideline covering the assessment and control of extractables and leachables of drug containers.

Argentina, Israel, Jordan And Saudi Arabia Join ICH As Observers

The International Council for Harmonisation appointed more observers at its latest meeting in Amsterdam and identified several new topics on which it plans to issue harmonized guidelines.

ICH Aims For Drug Quality Standards That Promote Continual Improvement, New Technology

ICH quality reflection paper outlines slate of guidelines to be adopted in near future, as well as a longer-term focus on training and implementation of its guidelines among a growing list of member countries around the world.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS125581

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel